Positive results of erdafitinib in the treatment of advanced urinary tract cancer
Treatment with the drug erdafitinib, an inhibitor of FGFR, is effective for advanced urinary tract cancer with alteration in the FGFR 2 or 3 genes. … Read more
Treatment with the drug erdafitinib, an inhibitor of FGFR, is effective for advanced urinary tract cancer with alteration in the FGFR 2 or 3 genes. … Read more
Scientists of the Tokyo University of Sciences (Japan) have discovered exactly how circulating free DNA (cfDNA,) is generated, the DNA that is found in small … Read more
Scientists from the Higher Council for Scientific Research (CSIC) have investigated the use of molecular mole cages ’formed by pseudopeptides with the aim of killing … Read more
Head and neck cancer produces 350,000 deaths each year in the world and 85 percent of cases are due to tobacco use, as reported by … Read more
Researchers of the Faculty of Medicine of the University of Virginia (United States) have identified “We have discovered a new non-coding RNA that may be … Read more
The US drug agency (FDA) has approved darolutamide, a non-steroidal androgen receptor antagonist, under the trade name of Nubeqa. The FDA-approved indication is the treatment … Read more
Spanish researchers from Integral Cancer Center Clara Campal HM CIOCC They have defined for the first time a series of molecular markers that identify those … Read more
Scientists at the Georgetown University Medical Center (United States) have discovered a mechanism that could explain why some cancers do not respond to a widely … Read more
Researchers at the Josep Carreras Leukemia Research Institute have described an epigenetic lesion that causes in breast cancer the “aberrant activity” of a hundred genes … Read more
Researchers of Molecular Therapy Research Group of the cancer of the Hospital del Mar Institute of Medical Research (IMIM) and doctors of the Hospital del … Read more